Filing Details
- Accession Number:
- 0001104659-23-122940
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-01 20:31:35
- Reporting Period:
- 2023-11-16
- Accepted Time:
- 2023-12-01 20:31:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1072379 | Northwest Biotherapeutics Inc | NWBO | Pharmaceutical Preparations (2834) | 943306718 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1629113 | Navid Malik | C/O Northwest Biotherapeutics, Inc. 48 Montgomery Lane, Suite 800 Bethesda MD 20814 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-11-16 | 125,000 | $0.84 | 445,000 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2023-11-17 | 150,000 | $0.82 | 295,000 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2023-11-17 | 295,000 | $0.82 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Dr. Malik sold a total of 570,000 shares solely to pay a tax obligation, and all proceeds are being used for such taxes.